DYRK1A and laminopathy: Treatment of T-CRO1 organoids with DYRK1A inhibitors for 40 days significantly reduced the DSB and p21 values, and restored the Lamin B1 levels (Fig. 8), demonstrating that this senescence and laminopathy-associated effect of DYRK1A can be, in principle, chemically counter-acted.